Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis. - Wikidata - wikimedia - TriplyDB

Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.

Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.

http://www.wikidata.org/entity/Q31171981

about

Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.Baseline psychophysiological and cortisol reactivity as a predictor of PTSD treatment outcome in virtual reality exposure therapy.An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials Exercise Augmentation of Exposure Therapy for PTSD: Rationale and Pilot Efficacy Data An Integrated Neuroscience Perspective on Formulation and Treatment Planning for Posttraumatic Stress Disorder: An Educational Review.Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.Differential Effects of D-Cycloserine and ACBC at NMDA Receptors in the Rat Entorhinal Cortex Are Related to Efficacy at the Co-Agonist Binding Site.Glutamatergic agents for OCD and related disorders D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders Harnessing reconsolidation to weaken fear and appetitive memories: A meta-analysis of post-retrieval extinction effects Adolescent social defeat alters N-methyl-D-aspartic acid receptor expression and impairs fear learning in adulthood.Increasing Neuroplasticity to Bolster Chronic Pain Treatment: A Role for Intermittent Fasting and Glucose Administration?Investigational drugs under development for the treatment of PTSD.A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.Bridging the Gap: Towards a cell-type specific understanding of neural circuits underlying fear behaviors Addiction, cognitive decline and therapy: seeking ways to escape a vicious cycle.Using model systems to understand errant plasticity mechanisms in psychiatric disorders.EFFECTS OF HOMEWORK COMPLIANCE ON COGNITIVE-BEHAVIORAL THERAPY WITH D-CYCLOSERINE AUGMENTATION FOR CHILDREN WITH OBSESSIVE COMPULSIVE DISORDER.The NMDA receptor partial agonist d-cycloserine does not enhance motor learning Brain connectomics predict response to treatment in social anxiety disorder.Gutsy Moves: The Amygdala as a Critical Node in Microbiota to Brain Signaling.RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.State-of-the-art and future directions for extinction as a translational model for fear and anxiety.

P2860

Q24187995-3E6A8E1E-9203-4B3B-AC39-B526DFD6A458 Q28082048-847222DA-89FF-4D46-B4B3-DE189741F554 Q30358603-670CABFE-B3BC-4BDA-9F56-2361B0F1289F Q30375098-2AF3F01D-4965-4D46-A35E-F621DA7EFDE5 Q30382252-B9C073BA-DC37-48AC-92EC-2B6124A5D40B Q33891691-5CB3D53A-4908-4074-AE08-48436473A08C Q34500045-C1644B6D-6D30-42AA-93FB-448B10B3F9EB Q35699606-EEF6B5CF-8DCD-4B2B-AD5B-0A8174628113 Q35967025-E241C183-9974-43EE-BA53-6B25DC58DCD3 Q36304362-869A827C-3908-454C-8237-DA38C11C8D31 Q36461648-294B1A79-2F98-46FB-8901-B05F08BB7170 Q36599325-A39D0F89-91E0-47A6-828B-DDD82242BF9A Q36696580-7F39C746-314A-4E35-A452-09557C4A44DE Q36776371-551B957D-E190-457C-B969-2D8E39AB6FD1 Q38378939-56E3FEF7-7C79-42BF-B011-622AF12F4D9D Q38851779-F1DB365A-94CB-48A3-95A2-D0D34EBDCF9E Q38911889-FFE7B818-8D0A-46EF-9778-0CC6FDA1D68B Q38940577-58E602AC-C74C-4E1E-BA16-AEC744053CC2 Q38992288-21F50845-DEEA-4101-AB62-F92D90469D06 Q40537511-68AADC3C-BFB6-4EEB-B570-2268E30BE3F9 Q41476154-7FAB9680-9C8D-49B2-9710-90CA00B4EF74 Q43718387-B0F3131B-4F64-413C-A9D2-EA62DEF76450 Q47610464-FF82E12B-F6F6-40DE-ACB0-C82F95CEC696 Q48669254-EF0DAD62-C225-4E78-B848-962166D221EB Q50423855-F39F8BC1-A372-4F95-A161-F3B12678B055

P2860

Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.

http://www.wikidata.org/entity/Q31171981

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Does D-cycloserine enhance exp ...... rs in humans? A meta-analysis.

@ast

Does D-cycloserine enhance exp ...... rs in humans? A meta-analysis.

@en

type

label

Does D-cycloserine enhance exp ...... rs in humans? A meta-analysis.

@ast

Does D-cycloserine enhance exp ...... rs in humans? A meta-analysis.

@en

prefLabel

Does D-cycloserine enhance exp ...... rs in humans? A meta-analysis.

@ast

Does D-cycloserine enhance exp ...... rs in humans? A meta-analysis.

@en

P1433

Q31171981-C7940734-B34E-45E7-B747-282598D6F5EB

P1476

Q31171981-0CD094D1-2173-4D2F-829F-3A456950B5B5

P2093

Q31171981-214FE74E-4F13-4ECB-BBF4-D9C94D7E9C8F

Q31171981-69EFA5A7-034B-4967-9464-9CB3A0AAFC34

Q31171981-7587F2B4-B030-4B79-84C5-448D6F517085

Q31171981-AA1026DF-001F-499B-9118-56ED9A4531E3

Q31171981-B440671F-0046-4184-BEAF-B43849DD175F

Q31171981-B7777942-5CA3-4D34-A827-C95F96A16878

Q31171981-FA6A526A-C184-4A9A-9B0D-0FB387625E2F

P275

Q31171981-3A1E01B0-E632-441E-9791-9D57B9D379D5

P2860

Q31171981-02F1A209-4FC4-412D-8CB3-61AC320AC379

Q31171981-03AF2B4F-61E6-412C-93B2-87B061C1A1E3

Q31171981-068B2AAF-756A-487B-80DC-730FAD28A0DF

Q31171981-0F8C749B-617B-4857-8D82-AA34AA9743EC

Q31171981-166760C3-34ED-4999-BEC7-A0E8F1E52C1F

Q31171981-1A30D9A1-D5B4-47CB-AB64-696412D76044

Q31171981-21471007-FA96-42AC-B257-077E5FE1C479

Q31171981-27E49297-B18C-4A23-9082-A18DBE710F79

Q31171981-2B82630C-F665-48C9-B5E7-C2BE84415143

Q31171981-323C06F6-9900-42AA-98B8-9CBBB40E98F3

P304

Q31171981-DF1ACFFB-2A87-4E36-92C7-9FCB72687DFB

P31

Q31171981-7634B110-CD67-419E-B392-2968AED8D86E

Q31171981-E6583732-95C1-4979-AC2D-53A2ADCAE1CC

Q31171981-c074635b-4176-4e00-9584-5cfeaef107fc

P356

Q31171981-8F0C44ED-0D3D-4C95-A178-71954F2F21E5

P407

Q31171981-03B9C424-D070-43BC-8C89-62C9B90FA356

P433

Q31171981-E86AF480-A92B-4FE7-9F06-560E69BD4812

P478

Q31171981-42D2E6A7-F6BC-45BA-BBBE-7870E2136B83

P577

Q31171981-750F54AB-9A75-4BC3-9768-3ECCDE0668EB

P5875

Q31171981-A9AB514B-22D1-441D-BEA6-85924DC49E49

P698

Q31171981-196EAA04-6801-4387-80A0-BCEDBCEA2CFB

P921

Q31171981-5266FA9D-32A7-4825-91EA-28CFFB409E27

Q31171981-A8EF6386-EEAA-4A09-B020-6C1DD70633FD

Q31171981-B5F8001B-6E54-45AD-9DFC-C276CBC48BFC

Q31171981-D02C1E78-BEE6-4C02-BB82-5CC28B50CD19

P932

Q31171981-C45B5703-6569-455D-B2B9-7584BD0230FB

P356

JOURNAL.PONE.0093519

P1433

P1476

Does D-cycloserine enhance exp ...... rs in humans? A meta-analysis.

@en

P2093

Alessandra Lopes

http://www.w3.org/2001/XMLSchema#string

Evandro Silva Freire Coutinho

http://www.w3.org/2001/XMLSchema#string

Helga Rodrigues

http://www.w3.org/2001/XMLSchema#string

Ivan Figueira

http://www.w3.org/2001/XMLSchema#string

Mauro Vitor Mendlowicz

http://www.w3.org/2001/XMLSchema#string

Paula Ventura

http://www.w3.org/2001/XMLSchema#string

Raquel Gonçalves

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials

Randomized, Placebo-Controlled Trial of Exposure and Ritual Prevention, Clomipramine, and Their Combination in the Treatment of Obsessive-Compulsive Disorder

Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine

Quantifying heterogeneity in a meta-analysis

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

An empirically derived inventory to measure social fears and anxiety: The Social Phobia and Anxiety Inventory.

A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder

Quality of life in individuals with anxiety disorders.

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder.

P304

e93519

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0093519

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263711399

http://www.w3.org/2001/XMLSchema#string

P698

24991926

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

mechanism of action

anxiety disorder

P932

4081005

http://www.w3.org/2001/XMLSchema#string